Optune Lua for the treatment of Non-small cell lung cancer*

*stage IV, non-squamous, non-small cell lung cancer, in combination with Pemetrexed (Alimta), after failure of first line treatments.

Optune Lua NSCLC user manual

Current revision: 03

Published on: 15 November 2022

Please select language to view or download this document: